Edwin Pun Hui Selected Research

Neoplasms (Cancer)

1/2018	Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization.
5/2016	Transarterial Ethanol Ablation for Unresectable Hepatocellular Carcinoma: Analysis of Clinical and Tumor Outcomes.
6/2015	Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.
2/2014	Unresectable hepatocellular carcinoma: randomized controlled trial of transarterial ethanol ablation versus transcatheter arterial chemoembolization.
1/2014	Epstein-Barr virus as a paradigm in nasopharyngeal cancer: from lab to clinic.
12/2013	Advanced technologies for studying circulating tumor cells at the protein level.
6/2013	Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer.
3/2012	CXCR6 and CCR5 localize T lymphocyte subsets in nasopharyngeal carcinoma.
12/2011	Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma.
10/2011	Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edwin Pun Hui Research Topics

Disease

12	Neoplasms (Cancer) 01/2018 - 01/2005
6	Nasopharyngeal Carcinoma 01/2020 - 01/2005
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2013
4	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 03/2008
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021 - 06/2013
2	Disease Progression 01/2021 - 01/2013
2	Circulating Neoplastic Cells 12/2013 - 02/2009
2	Colorectal Neoplasms (Colorectal Cancer) 02/2009 - 07/2008
1	Carcinoma (Carcinomatosis) 06/2015
1	Dermatitis 06/2013
1	Squamous Cell Carcinoma of Head and Neck 06/2013
1	Head and Neck Neoplasms (Head and Neck Cancer) 06/2013
1	Injection Site Reaction 06/2013
1	Fever (Fevers) 06/2013
1	Neutropenia 06/2013
1	Fatigue 06/2013
1	Exanthema (Rash) 06/2013
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 06/2013
1	Necrosis 12/2011
1	Febrile Neutropenia 10/2011

Drug/Important Bio-Agent (IBA)

3	TeaIBA 02/2022 - 02/2014
3	Ethanol (Ethyl Alcohol)IBA 02/2022 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 12/2013 - 07/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2015 - 12/2011
2	Pharmaceutical PreparationsIBA 06/2013 - 01/2005
1	Yttrium-90IBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	AlpelisibIBA 01/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2015
1	thiamine triphosphorate (TTP)IBA 02/2014
1	Biological ProductsIBA 12/2013
1	1- (3- C- ethynylribopentofuranosyl)cytosineIBA 06/2013
1	PlatinumIBA 06/2013
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 06/2013
1	LigandsIBA 03/2012
1	ChemokinesIBA 03/2012
1	Chemokine ReceptorsIBA 03/2012
1	Docetaxel (Taxotere)FDA Link 12/2011
1	Sunitinib (Sutent)FDA Link 12/2011
1	Keratins (Keratin)IBA 02/2009
1	AntigensIBA 02/2009
1	Fluorouracil (Carac)FDA LinkGeneric 07/2008
1	Ethiodized Oil (Ethiodol)FDA Link 03/2008
1	Cetuximab (Erbitux)FDA Link 01/2005

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2017 - 10/2011
4	Therapeutics 01/2020 - 03/2012
2	Adjuvant Chemotherapy 01/2021 - 01/2020
2	Radiotherapy 01/2021 - 06/2015
1	Induction Chemotherapy 01/2020
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2020
1	Hepatectomy 01/2018
1	Chemoradiotherapy 01/2013